Jackson Wealth Management LLC Increases Holdings in Lam Research Co. (NASDAQ:LRCX)

Jackson Wealth Management LLC grew its holdings in shares of Lam Research Co. (NASDAQ:LRCX) by 906.2% in the 4th quarter, HoldingsChannel reports. The firm owned 100,362 shares of the semiconductor company’s stock after acquiring an additional 90,388 shares during the quarter. Jackson Wealth Management LLC’s holdings in Lam Research were worth $7,249,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the business. Groesbeck Investment Management Corp NJ raised its stake in Lam Research by 806.4% in the 4th quarter. Groesbeck Investment Management Corp NJ now owns 31,940 shares of the semiconductor company’s stock valued at $2,307,000 after acquiring an additional 28,416 shares during the period. Hager Investment Management Services LLC bought a new stake in Lam Research in the 4th quarter valued at about $120,000. Stratos Investment Management LLC bought a new stake in Lam Research in the 4th quarter valued at about $216,000. Stratos Wealth Partners LTD. bought a new stake in Lam Research in the 4th quarter valued at about $7,852,000. Finally, Yousif Capital Management LLC raised its stake in Lam Research by 816.7% in the 4th quarter. Yousif Capital Management LLC now owns 163,070 shares of the semiconductor company’s stock valued at $11,779,000 after acquiring an additional 145,281 shares during the period. 84.61% of the stock is owned by hedge funds and other institutional investors.

Lam Research Stock Performance

NASDAQ:LRCX opened at $79.91 on Wednesday. The business has a 50 day moving average of $76.18 and a 200 day moving average of $78.44. The company has a market capitalization of $102.82 billion, a price-to-earnings ratio of 24.27, a PEG ratio of 1.34 and a beta of 1.46. Lam Research Co. has a 1-year low of $68.87 and a 1-year high of $113.00. The company has a debt-to-equity ratio of 0.51, a current ratio of 2.54 and a quick ratio of 1.73.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, January 29th. The semiconductor company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Lam Research had a return on equity of 51.86% and a net margin of 26.49%. On average, sell-side analysts predict that Lam Research Co. will post 3.69 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on LRCX shares. The Goldman Sachs Group lowered their price objective on Lam Research from $96.00 to $85.00 and set a “buy” rating on the stock in a research note on Friday, January 10th. B. Riley reduced their target price on Lam Research from $132.50 to $105.00 and set a “buy” rating for the company in a report on Wednesday, October 23rd. KeyCorp raised Lam Research from a “sector weight” rating to an “overweight” rating and set a $95.00 target price for the company in a report on Friday, January 17th. Wells Fargo & Company lifted their target price on Lam Research from $82.00 to $85.00 and gave the company an “equal weight” rating in a report on Thursday, January 30th. Finally, Wolfe Research lowered Lam Research from an “outperform” rating to a “peer perform” rating in a report on Wednesday, January 15th. Seven analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, Lam Research has a consensus rating of “Moderate Buy” and a consensus price target of $95.72.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.